How to optimize the design and implementation of risk prediction tools: focus group with patients with IgA nephropathy

Table 1 Focus group participant characteristics

Gender	Age	Race	eGFR (mL/min/1.73m²)	Proteinuria (g/d)	Kidney biopsy	Ever treated with immuno-suppression	Currently on immuno-suppression	On renin-angiotensin system blocker
Male	55	Caucasian	29	0.40	Sept 2009	Yes	Yes	Yes
Male	41	Caucasian	60	0.63	Apr 1998	No	No	Yes
Male	47	Caucasian	55	0.36	Oct 2014	Yes	Yes	Yes
Male	35	Caucasian	71	1.41	Sept 2011	Yes	No	Yes
Male	54	Caucasian	56	0.65	Oct 2016	Yes	No	Yes

ISSN: 1472-6947